Gastrointestinal Infection Testing Market Overview
The report is titled as ‘Gastrointestinal Infection Testing Market: Opportunity Analysis and Future Assessment 2022-2030’. An overview of conceptual frameworks, analytical approaches of the Gastrointestinal Infection Testing market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Gastrointestinal Infection Testing market is expected to grow with significant rate in the near future.
In 2020, global gastrointestinal infection testing market was valued at US$ XXX Mn and expected to grow significantly at a CAGR of XXX % over the forecast period
Gastrointestinal Infection Testing Introduction
Gastrointestinal infections can be understood as bacterial, viral, or parasitic infections inducing gastroenteritis comprising both the small intestine and the stomach. The signs and symptoms of these gastrointestinal infections comprise abdominal pain, vomiting, and diarrhea. The elderly, young children, and immuno-compromised patients are considered more prone and at highest risks for such severe complications and chronic disease. Factors such as lack of water supplies, poor sanitation, and soaring globalization of food transport systems all make them susceptible to the formation of enormous epidemics of food and waterborne outbreaks of gastrointestinal infections and disorders. The diagnosis and affirmation of these gastrointestinal infections is likely to be carried out by means of several laboratory tests and point-of-care tests.
Notably, gastrointestinal infections, particularly diarrheal diseases, are accountable for significant morbidity and mortality all across the world. The quick diagnosis and timely and appropriate treatment are for that reason necessary in these circumstances. The high prevalence of gastrointestinal infections among the population, worldwide, owing to poor eating habits and unhealthy diets, is primarily projected to thustr the market growth in the near future. In addition to that, the rapid growth in prevalence of diarrhea due to factors like unseemly sanitation facilities, inadequacy of appropriate medical facilities, and unhygienic behavior of people, particularly in emerging economies, is also estimated to hold a major role in accelerating the growth of the global gastrointestinal infection testing market in the coming years.
Growing incidence of gastrointestinal infections and digestive diseases worldwide owing to unhealthy food habits
Intestines are essentially a vital component of the digestive system. Aside from assisting assimilation and soaking up of foods, they also facilitate in building immunity. The intestinal microbiome is basically an intricate system comprising of an infinite number of microorganisms and bacteria that help in immersion of nutrients and yield energy, whilst safeguarding the human body from viruses and injurious bacteria. Having said that, swift improvement and modernization of lifestyle along with ill dietary habits have paved its way to an enormous change in the working of the intestinal system. In point of fact, a novel study contends that the freshly adapted dietary and sanitary habits is likely to have paved its way to a decline in the bacteria 'Prevotella copri', an ordinary human gut microbe that assists in digestion. The researchers and scientists freshly ascertained that there was a definite extent of reduction in the bacteria in the modern generation that could be accredited to industrialization, autoimmune and gastrointestinal disorders, conditions like allergies, and obesity. Lethargic lifestyle in an urban environment introduced in alterations in diet, which is moderately low in fibers and higher in fat content. It also paved its way to the establishment of new hygiene habits and the extensive usage of antibiotics and other medical products.
The scientists and investigators reckon that all these factors are likely to have endowed to distressing the fragile balance of the intestinal microbiome, which may cause digestive disorders. Notably, a regimen that is relatively low in fibers and high in trans and saturated fats is likely to affect intestinal flora formulation and reduce intestinal flora multiplicity, paving its way to gastrointestinal infection and digestive diseases, in accordance with the research issued in the World Journal of Gastroenterology. Thus, the soaring prevalence of gastrointestinal infections and digestive issues all around the world attributing to il dietary habits is likely to drive the growth of the global gastro intestinal infection testing market in the following years.
Gastrointestinal Infection Testing Market Segmentation
The global gastrointestinal infection testing market is segmented on the basis of product type, technique, test type, pathogenic group, end user, and region.
By Product Type
Sequencing Kits
Equipment
By Technique
Nucleic acid amplification techniques
DNA sequencing and typing
Direct molecular probe techniques
Nucleic acid quantitation
Bacteriological Culture Technique
Biochemical Technique
Conventional Technique
Standard Plate Count
Membrane filters
Others
By Test Type
Endoscopy
Biopsy
Colonoscopy
Sigmoidoscopy
X-Ray
Ultrasound
Others
Enterotoxigenic E. Coli (ETEC)
Enteroinvasive E. Coli (EIEC)
Verotoxin Producing E. Coli (EHEC)
Enteropathogenic E. Coli (EPEC)
By End User
Diagnostic Laboratories
Research Institutes
By Region
North America
Latin America
Asia Pacific
Europe
Middle East
Africa
Gastrointestinal Infection Testing Market Key Players
Some of the key participating players in global gastrointestinal infection testing market are:
Becton, Dickinson, and Company (BD)
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories Inc.
Luminex Corporation
Hoffmann-La Roche Ltd.
bioMérieux SA
Quidel Corporation
Illumina, Inc.
Seegene Inc
Genetic Signatures
Nanotek Inc
Hologic Inc
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
New product designs and launches
Current product compliance
Reimbursement
Concerns for use of Gastrointestinal Infection Testing
Advantages of Gastrointestinal Infection Testing
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s product sales, previous growth rates and market expansion plans are considered to generate market share in the market.
Summarized Info | Details | ||
---|---|---|---|
Base Year: | 2021 | Forecast Period: | 2022-2030 |
Key Geographies: |
|
||
Market Segmentation: |
|
||
Key Players: |
Becton, Dickinson, and Company (BD), Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Luminex Corporation, Hoffmann-La Roche Ltd., bioMérieux SA, Quidel Corporation, Illumina, Inc., Seegene Inc, Genetic Signatures, Nanotek Inc, and Hologic Inc |
||
Report Coverage: |
|
||
Market Size: | US$ 725.8 Mn in 2030 | CAGR: | XX% |
To learn more about this report, request a free sample copy
The gastrointestinal infection testing market is estimated to reach at a value of US$ *** Mn by the end of 2022 and expected to reach at a value of US$ *** Mn by 2030 with a significant CAGR of ***%.
The base year for the report is 2021 in gastrointestinal infection testing market.
The global gastrointestinal infection testing market is segmented on the basis of product type, technique, test type, pathogenic group, end user, and region
Becton, Dickinson, and Company (BD), Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Luminex Corporation, Hoffmann-La Roche Ltd., bioMérieux SA, Quidel Corporation, Illumina, Inc., Seegene Inc, Genetic Signatures, Nanotek Inc, and Hologic Inc